Kiniksa Pharmaceuticals, Ltd. - (KNSA) Social Stream



Kiniksa Pharmaceuticals, Ltd. - (KNSA): $12.83

-0.12 (-0.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Kiniksa Pharmaceuticals Ltd (KNSA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Kiniksa Pharmaceuticals Ltd.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-28 3 $37 $26 $30 $10.91 174.98%
2021-12-29 3 $34 $25.91 $28.97 $10.91 165.54%
2022-02-22 3 $34 $27 $29.666 $10.91 171.92%
2022-03-23 3 $28 $24 $25.666 $10.91 135.25%

The Trend in the Analyst Price Target


Over the past 40 weeks, KNSA's average price target has gone down $6.33.

Over the past 50 weeks, KNSA's average upside potential has been 132.88%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 2 40 25 34.20 17.69 93.33%
2021-05-15 2 37 25 32.75 14.13 131.78%
2021-06-14 2 37 25 32.00 15.24 109.97%
2021-11-03 3 37 26 30.00 15.06 99.2%
2021-12-03 3 37 26 30.00 11.85 153.16%

KNSA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


KNSA's average broker recommendation rating improved by 0.6 over the prior 151 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KNSA as an investment opportunity.

  • In the context of all US stocks, Kiniksa Pharmaceuticals Ltd's number of analysts covering the stock is higher than 44.56% of them.
  • In terms of how Kiniksa Pharmaceuticals Ltd fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 342.98% of that group.
  • Kiniksa Pharmaceuticals Ltd's variance in analysts' estimates is lower than 18.8% of Pharmaceutical Products stocks.
  • Kiniksa Pharmaceuticals Ltd's average analyst price target is greater than 260.3% of stocks in the small market cap category.

Stocks similar to Kiniksa Pharmaceuticals Ltd in the Pharmaceutical Products industry regarding analyst recommendations and price targets are KMPH, KMDA, and KALV.

What is the outlook for KNSA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5426 seconds.